Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2022-02-04

FDA Approved: TOPIRAMATE — Supplemental Application (Upsher-Smith Laboratories, LLC)

View source ↗

Summary

The FDA approved a supplemental application for Topiramate from Upsher-Smith Laboratories, LLC.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Topiramate (Topiramate)

Snippet

SUPPL AP for TOPIRAMATE (TOPIRAMATE)